27 Business research jobs at Center for Biologics Evaluation and Research (CBER) in united-state
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 7 hours ago
*Applications will be reviewed on a rolling-basis, and this opportunity will remain open until filled. A research opportunity is currently available in the Office of Blood Research and Review (OBRR
-
Applications will be reviewed on a rolling-basis, and this opportunity will remain open until filled. A research opportunity is currently available in the Office of Vaccine Research and Review (OVRR
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 7 hours ago
*Applications will be reviewed on a rolling-basis, and this opportunity will remain open until filled. A research opportunity is currently available in the Office of Vaccine Research and Review
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 7 hours ago
Applications will be reviewed on a rolling-basis and this opportunity will remain open until filled. A research opportunity is currently available in the Office of Vaccine Research and Review (OVRR
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 7 hours ago
*Applications will be reviewed on a rolling-basis, and this opportunity will remain open until filled. A research opportunity is currently available with the Office of Therapeutics Proteins (OTP
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 3 months ago
*Applications will be reviewed on a rolling-basis, and this opportunity will remain open until filled. A research opportunity is currently available with the Office of Therapeutics Proteins (OTP
-
Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 7 hours ago
*Applications will be reviewed on a rolling-basis. A research opportunity is currently available in the Office of Biostatistics and Pharmacovigilance (OBPV) at the Center for Biologics Evaluation